A phase I study of a first monoclonal antibody (n-CoDeR)

Trial Profile

A phase I study of a first monoclonal antibody (n-CoDeR)

Phase of Trial: Phase I

Latest Information Update: 18 Aug 2014

At a glance

  • Drugs Monoclonal antibodies (Primary)
  • Indications Unspecified
  • Focus Adverse reactions
  • Sponsors Bayer
  • Most Recent Events

    • 18 Aug 2014 New trial record
    • 07 Jul 2014 The first patient has been enrolled, according to a Bioinvent media release. This event triggered a milestone payment from Bayer.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top